Objective: To describe the experience of a research clinic diagnosing AD during the last two
decades, with special emphasis on patients who meet the National Institute of Neurological …

Despite the introduction of formal clinical criteria for Alzheimer disease (AD), the clinical
diagnosis of AD remains one of exclusion of other dementias. To determine the accuracy of …

Neuropathologic confirmation is required to validate the NINCDS-ADRDA Work Group
criteria for the clinical diagnosis of Alzheimer's disease (AD). Neuropathologic inclusion and …

Neuropathological examination confirmed the clinical diagnosis of possible or probable
Alzheimer disease (AD) in 90 of the first 100 patients who came to autopsy at the Johns …

Clinical investigations of Alzheimer's disease (AD) have been limited by diagnostic
inaccuracy. We employed explicit clinical inclusion and exclusion criteria to identify subjects …

For more than 25 years, the diagnosis of Alzheimer's disease (AD) has been based on the
National Institute of Neurological and Communicative Disorders and Stroke (NINCDS) and …

Because the clinical picture of Alzheimer disease (AD) is often difficult to discriminate from
other dementing illnesses, the diagnosis of AD requires neuropathological confirmation …

Objective Mixed pathologies are common in older persons with dementia. Little is known
about mixed pathologies in probable Alzheimer disease (AD) and about the spectrum of …

Publisher Summary This chapter describes that Alzheimer's disease (AD) is the most
prevalent form of dementia in individuals age 65 and older. The pathological substrate of the …

The National Institute on Aging and the Alzheimer's Association charged a workgroup with
the task of revising the 1984 criteria for Alzheimer's disease (AD) dementia. The workgroup …